SARS-CoV-2 vaccine development

Viečča ollesdeavstta
Series

The immune system response to the SARS-COV-2 virus

Viečča ollesdeavstta
Series

The paediatric response to the SARS-COV-2 virus and what we can learn from it

Viečča ollesdeavstta
Series

SARS-COV-2 vaccine development where are we now? /

Viečča ollesdeavstta
Series

The immune system response to the SARS-COV-2 virus an update /

Viečča ollesdeavstta
Series

Development of an intranasal vaccine for SARS-CoV-2

Viečča ollesdeavstta
Series

SARS-CoV-2 human monoclonal antibody therapy

Viečča ollesdeavstta
Series

Convalescent plasma therapy as a treatment for COVID-19

Viečča ollesdeavstta
Series

The development of SARS-CoV-2 vaccines

Viečča ollesdeavstta
Series

The immune system response to the SARS-CoV-2 virus July 2020 update /

Viečča ollesdeavstta
Series

Rheumatic diseases and COVID-19

Viečča ollesdeavstta
Series

Presence and function of SARS-CoV-2-specific T-cells in recovered patients and healthy volunteers

Viečča ollesdeavstta
Series

Potential long-term health effects of a SARS-CoV-2 infection

Viečča ollesdeavstta
Series

Imperial College London's saRNA Vaccine - COVAC1

Viečča ollesdeavstta
Series

Comparison of COVID-19 and seasonal HCoV pathologies and transfer to endemic state

Viečča ollesdeavstta
Series

SARS-COV-2 human monoclonal antibody therapy update

Viečča ollesdeavstta
Series

mRNA COVID-19 vaccine efficacy in recovered vs COVID-naive individuals

Viečča ollesdeavstta
Series

SARS-CoV-2 monoclonal antibody testing in vivo

Viečča ollesdeavstta
Series